The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV

First Published November 3, 2015 Research Article Find in PubMed

Authors

1
 
Precision Health Economics, Los Angeles, CA, USA
by this author
, 2
 
University of Southern California, Los Angeles, CA, USA
by this author
, 3
 
Bristol-Myers Squibb, Plainsboro, NJ, USA
by this author
,
3
 
Bristol-Myers Squibb, Plainsboro, NJ, USA
by this author
, 4
 
AbbVie, Chicago, IL, USA
by this author
, 4
 
AbbVie, Chicago, IL, USA
by this author
, 1
 
Precision Health Economics, Los Angeles, CA, USA
by this author
, 1
 
Precision Health Economics, Los Angeles, CA, USA
by this author
, 2
 
University of Southern California, Los Angeles, CA, USA
by this author
...
First Published Online: November 3, 2015

We investigated the effect of changes to state AIDS Drug Assistance Programs (ADAP) policies, which govern access to antiretroviral therapy (ART), on clinical and economic outcomes among low-income people living with HIV/AIDS. Retrospective analyses of ART access were conducted on state ADAP policies, using data from ADAP Monitoring Reports and Kaiser Family Foundation from 2006 to 2010. We found stricter eligibility requirements reduce the number of HIV-positive individuals with ART access through ADAP, and decreased ART use increases mortality by 2.67 quality-adjusted life years (QALYs) per beneficiary. If the ADAP income eligibility cutoff were decreased by 50 percentage points in each state, 4,626 individuals would lose ART access nationwide. Based on a $22,143 cost/QALY, this policy would save $274 million in health care expenditures (2012 dollars), but result in 12,352 QALYs lost, valued at $1.2 billion. Therefore, states should exercise caution in restricting programs that increase ART access for low-income people living with HIV/AIDS.

American Academy of HIV Medicine . (2013). ADAP. Retrieved from http://www.aahivm.org/adap
Google Scholar
American Academy of HIV Medicine . (2014). The Affordable Care Act: One year later. HIV Specialist Magazine. Retrieved from http://www.aahivm.org/hivspecialist
Google Scholar
American Public Health Association . (2013). Medicaid expansion. Retrieved from http://kff.org/medicaid/issue-brief/medicaid-a-primer/
Google Scholar
Bernell, S. L., Shinogle, J. A. (2005). The relationship between HAART use and employment for HIV-positive individuals: An empirical analysis and policy outlook. Health Policy, 71, 255-264.
Google Scholar | Crossref | Medline
Bhattacharya, J., Goldman, D., Sood, N. (2003). The link between public and private insurance and HIV-related mortality. Journal of Health Economics, 22, 1105-1122.
Google Scholar | Crossref | Medline
Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., Roberts, M. S. (2008). What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Medical Care, 46, 349-356.
Google Scholar | Crossref | Medline
Bristol-Myers Squibb Company . (2013). Highlights of prescribing information: Sustiva. Retrieved from http://packageinserts.bms.com/pi/pi_sustiva.pdf
Google Scholar
Brogan, A. J., Talbird, S. E., Cohen, C. (2011). Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naive adults with HIV infection in the United States. Value in Health: The journal of the International Society for Pharmacoeconomics and Outcomes Research, 14, 657-664.
Google Scholar | Crossref | Medline
Brown, J. R., Finkelstein, A. (2008). The interaction of public and private insurance: Medicaid and the long-term care insurance market. American Economic Review, 98, 1083-1102.
Google Scholar | Crossref | ISI
Bureau of Labor Statistics . (2012). Consumer price index. Retrieved from http://www.bls.gov/cpi/
Google Scholar
Card, D., Shore-Sheppard, L. D. (2004). Using discontinuous eligibility rules to identify the effects of the federal Medicaid expansions on low-income children. Review of Economics and Statistics, 86, 752-766.
Google Scholar | Crossref
Centers for Disease Control and Prevention . (n.d.). HIV surveillance reports, 1996-2010. Retrieved from http://www.cdc.gov/hiv/library/reports/surveillance/index.html
Google Scholar
Centers for Medicare & Medicaid Services . (2013). Medicaid Statistical Information System (MSIS) state summary datamarts. Retrieved from http://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-and-Systems/MedicaidDataSourcesGenInfo/MSIS-Mart-Home.html
Google Scholar
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., . . .Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493-505.
Google Scholar | Crossref | Medline | ISI
Congressional Budget Office . (2012, July). Estimates for the insurance coverage provisions of the Affordable Care Act updated for the recent Supreme Court decision. Retrieved from http://www.cbo.gov/sites/default/files/cbofiles/attachments/43472-07-24-2012-CoverageEstimates.pdf
Google Scholar
Congressional Budget Office . (2013). CBO’s May 2013 estimate of the effects of the Affordable Care Act on health insurance coverage. Retrieved from http://www.cbo.gov/sites/default/files/cbofiles/attachments/43900-2013-05-ACA.pdf
Google Scholar
Crowley, J., Kates, J. (2012). The Affordable Care Act, the Supreme Court, and HIV: What are the implications. Menlo Park, CA: Kaiser Family Foundation.
Google Scholar
Crowley, J. S., Kates, J. (2013, April). Updating the Ryan White program for a new era: Key issues and questions for the future. Retrieved from http://kaiserfamilyfoundation.files.wordpress.com/2013/04/8431.pdf
Google Scholar
Cutler, D. M., Gruber, J. (1996). Does public insurance crowd out private insurance? Quarterly Journal of Economics, 111, 391-430.
Google Scholar | Crossref | ISI
Cutler, D. M., Richardson, E., Keeler, T. E., Staiger, D. (1997). Measuring the health of the US population. Brookings Papers on Economic Activity. Microeconomics, 1997, 217-282.
Google Scholar | Crossref
Cutler, D. M., Rosen, A. B., Vijan, S. (2006). The value of medical spending in the United States, 1960-2000. New England Journal of Medicine, 355, 920-927.
Google Scholar | Crossref | Medline
Detels, R., Muñoz, A., McFarlane, G., Kingsley, L. A., Margolick, J. B., Giorgi, J., . . .Phair, J. P. (1998). Effectiveness of potent antiretroviral therapy on time to aids and death in men with known HIV infection duration. Journal of the American Medical Association, 280, 1497-1503.
Google Scholar | Crossref
Doshi, R. K., Milberg, J., Isenberg, D., Matthews, T., Malitz, F., Matosky, M., . . .Cheever, L. W. (2015). High rates of retention and viral suppression in the US HIV safety net system: HIV care continuum in the Ryan White HIV/AIDS Program, 2011. Clinical Infectious Disease, 60, 117-125. doi:10.1093/cid/ciu722
Google Scholar | Crossref | Medline
El-Sadr, W. M., Lundgren, J., Neaton, J. D., Gordin, F., Abrams, D., Arduino, R. C., . . .Rappoport, C. (2006). CD4+ count-guided interruption of antiretroviral treatment. New England Journal of Medicine, 355, 2283-2296.
Google Scholar | Crossref | Medline | ISI
Fernandez, B., Gabe, T. (2013). Health insurance premium credits in the Patient Protection and Affordable Care Act (ACA). Retrieved from https://www.fas.org/sgp/crs/misc/R41137.pdf
Google Scholar
Freedberg, K. A., Losina, E., Weinstein, M. C., Paltiel, A. D., Cohen, C. J., Seage, G. R., . . .Goldie, S. J. (2001). The cost effectiveness of combination antiretroviral therapy for HIV disease. New England Journal of Medicine, 344, 824-831.
Google Scholar | Crossref | Medline
Godwin, N. C., Willig, J. H., Nevin, C. R., Lin, H. Y., Allison, J., Gaddis, K., . . .Raper, J. L. (2011). Underutilization of the AIDS Drug Assistance Program: Associated factors and policy implications. Health Services Research, 46, 982-995.
Google Scholar | Crossref | Medline
Goldman, D. P., Bao, Y. (2004). Effective HIV treatment and the employment of HIV+ adults. Health Services Research, 39(6 Pt 1), 1691-1712.
Google Scholar | Crossref | Medline
Goldman, D. P., Bhattacharya, J., Leibowitz, A. A., Joyce, G. F., Shapiro, M. F., Bozzette, S. A. (2001). The impact of state policy on the costs of HIV infection. Medical Care Research and Review, 58, 31-53.
Google Scholar | SAGE Journals | ISI
Goldman, D. P., Leibowitz, A. A., Joyce, G. F., Fleishman, J. A., Bozzette, S. A., Duan, N., Shapiro, M. F. (2003). Insurance status of HIV-infected adults in the post-HAART era: Evidence from the United States. Applied Health Economics and Health Policy, 2, 85-90.
Google Scholar | Medline
Gopalappa, C., Farnham, P. G., Hutchinson, A. B., Sansom, S. L. (2012). Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes, 61, 99-105.
Google Scholar | Crossref | Medline
Grimes, R. M., Shenouda, T. A. (2013). Using cost as a consideration for antiretroviral regimen selection: An example using average wholesale prices. AIDS Care, 25, 1380-1384.
Google Scholar | Crossref | Medline
Gruber, J., Simon, K. (2008). Crowd-out 10 years later: Have recent public insurance expansions crowded out private health insurance? Journal of Health Economics, 27, 201-217.
Google Scholar | Crossref | Medline
Hanna, D. B., Buchacz, K., Gebo, K. A., Hessol, N. A., Horberg, M. A., Jacobson, L. P., . . .Gange, S. J. (2013). Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One, 8, e78952. doi:10.1371/journal.pone.0078952
Google Scholar | Crossref | Medline
Health Resources and Services Administration . (2012). Justification of Estimates for Appropriations Committees. Retrieved from http://www.hrsa.gov/about/budget/budgetjustification2012.pdf
Google Scholar
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., Weissert, W. G. (2000). Willingness to pay for a quality-adjusted life year: In search of a standard. Medical Decision Making, 20, 332-342.
Google Scholar | SAGE Journals
Julg, B., Goebel, F. D. (2006). Treatment interruption in HIV therapy: A SMART strategy? Infection, 34, 186-188.
Google Scholar | Crossref | Medline
Kaiser Family Foundation . (2011). State health facts: Medicaid & CHIP. Retrieved from http://www.statehealthfacts.org/comparecat.jsp?cat=4&rgn=6&rgn=1
Google Scholar
Kaiser Family Foundation . (2012). The Medicaid Medically Needy Program: Spending and enrollment update. Retrieved from http://kff.org/medicaid/issue-brief/the-medicaid-medically-needy-program-spending-and/
Google Scholar
Kaiser Family Foundation . (2013, March). HIV/AIDS policy fact sheet: The Ryan White Program. Retrieved from http://kaiserfamilyfoundation.files.wordpress.com/2013/03/7582-07.pdf
Google Scholar
Kates, J. (2011). Medicaid and HIV: A national analysis. Menlo Park, CA: Kaiser Family Foundation. Retrieved from http://kaiserfamilyfoundation.files.wordpress.com/2013/01/8218.pdf
Google Scholar
Kates, J. (2012). How the ACA changes pathways to insurance coverage for people with HIV. Retrieved from http://kff.org/health-reform/perspective/how-the-aca-changes-pathways-to-insurance-coverage-for-people-with-hiv/
Google Scholar
Kates, J., Garfield, R., Young, K., Quinn, K., Frazier, E., Skarbinski, J. (2014). Assessing the impact of the Affordable Care Act on health insurance coverage of people with HIV. Menlo Park, CA: Kaiser Family Foundation.
Google Scholar
Burwell, King v. No. 14-114, 135 475 (Supreme Court 2014).
Google Scholar
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., . . .Moore, R. D. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine, 360, 1815-1826.
Google Scholar | Crossref | Medline
Kuhn, L., Aldrovandi, G. M., Sinkala, M., Kankasa, C., Mwiya, M., Thea, D. M. (2010). Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to-child HIV transmission. AIDS, 24, 1374-1377.
Google Scholar | Crossref | Medline
Martin, E. G., Wang, K. H. (2013). Integrating substance abuse treatment into HIV care: Missed opportunities in the AIDS Drug Assistance Program. Journal of Acquired Immune Deficiency Syndromes, 62, 421-429.
Google Scholar | Crossref | Medline
Mauskopf, J. (2013). A methodological review of models used to estimate the cost effectiveness of antiretroviral regimens for the treatment of HIV infection. Pharmacoeconomics, 31, 1031-1050.
Google Scholar | Crossref | Medline
McManus, K. A., Engelhard, C. L., Dillingham, R. (2013). Current challenges to the United States’ AIDS drug assistance program and possible implications of the Affordable Care Act. AIDS Research and Treatment, 2013, 350169.
Google Scholar | Crossref | Medline
McManus, K. A., Pinkerton, R., Dillingham, R. (2014). Effects of recent Virginia AIDS Drug Assistance Program policy changes on diabetes and hyperlipidemia control in people living with HIV. SAGE Open Medicine, 2, 2050312114532809.
Google Scholar | SAGE Journals
National Alliance of State & Territorial AIDS Directors . (2012). National ADAP Monitoring Project annual report.
Google Scholar
Olson, K. M., Godwin, N. C., Wilkins, S. A., Mugavero, M. J., Moneyham, L. D., Slater, L. Z., Raper, J. L. (2014). A qualitative study of underutilization of the AIDS drug assistance program. Journal of the Association of Nurses in AIDS Care, 25, 392-404. doi:10.1016/j.jana.2013.11.003
Google Scholar | Crossref | Medline
Panel on Antiretroviral Guidelines for Adults and Adolescents . (2014). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
Google Scholar
Patient Protection and Affordable Care Act . (2010). 42 U.S.C. § 18001.
Google Scholar
Pinkerton, S. D., Kibicho, J., Galletly, C. L. (2013). Is the US AIDS drug assistance program cost-effective? AIDS and Behavior, 17(1), 1-4.
Google Scholar | Crossref | Medline
Price, C. C., Eibner, C. (2013). For states that opt out of Medicaid expansion: 3.6 million fewer insured and $8.4 billion less in federal payments. Health Affairs, 32, 1030-1036.
Google Scholar | Crossref
Romley, J., Juday, T., Solomon, M., Seekins, D., Brookmeyer, R., Goldman, D. (2014). Early HIV treatment led to life expectancy gains valued at $80 billion for persons infected between 1996 and 2009. Health Affairs, 33, 370-377.
Google Scholar | Crossref
Snider, J. T., Juday, T., Romley, J., Seekins, D., Rosenblatt, L., Goldman, D. P. (2014). Nearly 60,000 uninsured, low-income people with HIV/AIDS live in states that are not moving forward with Medicaid expansion under the Affordable Care Act. Health Affairs, 33, 386-393.
Google Scholar | Crossref
Sprague, C., Simon, S. E. (2014). Understanding HIV care delays in the US South and the role of the social-level in HIV care engagement/retention: A qualitative study. International Journal for Equity in Health, 13, 28.
Google Scholar | Crossref | Medline
Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., . . .Ruiz, N. M. (1999). Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. New England Journal of Medicine, 341, 1865-1873.
Google Scholar | Crossref | Medline | ISI
Tennant, S. J., Hester, E. K., Caulder, C. R., Lu, Z. K., Bookstaver, P. B. (2015). Adherence among rural HIV-infected patients in the Deep South: A comparison between single-tablet and multi-tablet once-daily regimens. Journal of the International Association of Providers of AIDS Care, 14(1), 64-71.
Google Scholar | SAGE Journals
U.S. Census Bureau . (n.d.). Population estimates. Historical data: 2000s. Retrieved from http://www.census.gov/popest/data/historical/2000s/index.html
Google Scholar
Ubel, P. A., Hirth, R. A., Chernew, M. E., Fendrick, A. M. (2003). What is the price of life and why doesn’t it increase at the rate of inflation? Archives of Internal Medicine, 163, 1637-1641.
Google Scholar | Crossref | Medline
Viscusi, W. K., Aldy, J. E. (2003). The value of a statistical life: A critical review of market estimates throughout the world. Journal of Risk and Uncertainty, 27(1), 5-76.
Google Scholar | Crossref | ISI
Walensky, R. P., Sax, P. E., Nakamura, Y. M., Weinstein, M. C., Pei, P. P., Freedberg, K. A., . . .Schackman, B. R. (2013). Economic savings versus health losses: The cost-effectiveness of generic antiretroviral therapy in the United States. Annals of Internal Medicine, 158(2), 84-92.
Google Scholar | Crossref | Medline
Yazici, E. Y., Kaestner, R. (1998). Medicaid expansions and the crowding out of private health insurance. Cambridge, MA: National Bureau of Economic Research.
Google Scholar | Crossref
Yi, T., Cocohoba, J., Cohen, M., Anastos, K., DeHovitz, J. A., Kono, N., . . .Hessol, N. A. (2011). The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. Journal of Acquired Immune Deficiency Syndromes, 56, 253-262.
Google Scholar | Crossref | Medline

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Access Options

    My Account

    Welcome
    You do not have access to this content.

    Chinese Institutions / 中国用户

    Click the button below for the full-text content

    请点击以下获取该全文

    Institutional Login

    does not have access to this content.

    If you have access to journal content via a university, library or employer, sign in here

    Purchase Content

    24 hours online access to download content

    Added to Cart

    Cart is full

    There is currently no price available for this item in your region.

    Research off-campus without worrying about access issues. Find out about Lean Library here


Purchase

MCR-article-ppv for GBP32.00
MCR-article-ppv for $41.50
Single Issue 24 hour E-access for GBP389.48
Single Issue 24 hour E-access for $466.66

Cookies Notification

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more.
Top